BRIEF-Catalyst Pharmaceuticals announces positive top-line PHASE 3 data from Firdapse clinical trial

* Announces positive top-line PHASE 3 data from Firdapse clinical trial in patients with lambert-eaton myasthenic syndrome
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.